speb/financial-data huggingface dataset:
DuPont ROE decomposition for CAAS (annual period ending 2022-12-31)
ROE: 6.82406120672541%
Net margin: 4.219234785695806%
Asset turnover: 0.7413026071180594
Equity multiplier (leverage): 2.181793747995663
EBIT margin: 2.205830977564012%
Interest burden factor: 1.972091430528208
Tax burden factor: 0.9699166521965619
ROE archetype: Standard Business
DuPont ROE decomposition for CAAS (annual period ending 2023-12-31)
ROE: 12.160592934405443%
Net margin: 7.4152343871995345%
Asset turnover: 0.7704301678210258
Equity multiplier (leverage): 2.1286124000551196
EBIT margin: 7.464509658994299%
Interest burden factor: 1.1211705638975407
Tax burden factor: 0.8860371099823781
ROE archetype: Standard Business
DuPont ROE decomposition for CAAS (annual period ending 2024-12-31)
ROE: 9.868807619131903%
Net margin: 5.82224031585335%
Asset turnover: 0.7950348625263939
Equity multiplier (leverage): 2.1320058046537804
EBIT margin: 6.961678201356511%
Interest burden factor: 0.9738502957012976
Tax burden factor: 0.8587840746867281
ROE archetype: Standard Business
DuPont ROE decomposition for CAAS (annual period ending 2025-12-31)
ROE: 12.592782471597106%
Net margin: 6.779359988298839%
Asset turnover: 0.8427082564162387
Equity multiplier (leverage): 2.20422415161838
EBIT margin: 7.774089242245368%
Interest burden factor: 1.0314300592988292
Tax burden factor: 0.8454723127035831
ROE archetype: Standard Business
DuPont ROE decomposition for CABO (annual period ending 2022-12-31)
ROE: 12.266424551157456%
Net margin: 12.48837221570617%
Asset turnover: 0.2477500117264415
Equity multiplier (leverage): 3.9645917582468195
EBIT margin: 31.321309017416326%
Interest burden factor: 0.7024599751101795
Tax burden factor: 0.5676025607212218
ROE archetype: Standard Business
DuPont ROE decomposition for CABO (annual period ending 2023-12-31)
ROE: 12.668385322580736%
Net margin: 13.385647057561584%
Asset turnover: 0.2459509278300048
Equity multiplier (leverage): 3.8479855235856477
EBIT margin: 32.15643344987518%
Interest burden factor: 0.7623936502406363
Tax burden factor: 0.5459994749584343
ROE archetype: Standard Business
DuPont ROE decomposition for CABO (annual period ending 2024-12-31)
ROE: 0.8032614188769762%
Net margin: 0.9167214293763635%
Asset turnover: 0.23778605168604194
Equity multiplier (leverage): 3.6849631459445007
EBIT margin: 28.806641418841668%
Interest burden factor: 0.5366374147551828
Tax burden factor: 0.0593012445889662
ROE archetype: Low Return
DuPont ROE decomposition for CABO (annual period ending 2025-12-31)
ROE: -22.074019946310305%
Net margin: -23.741410648431522%
Asset turnover: 0.2478772103724474
Equity multiplier (leverage): 3.7509243978486966
EBIT margin: 25.95144739357263%
Interest burden factor: -0.7863032894382265
ROE archetype: Low Return
DuPont ROE decomposition for CAD.V (quarterly period ending 2025-01-31)
ROE: -2.467701739314366%
Asset turnover: 0
Equity multiplier (leverage): 1.0063182523429755
ROE archetype: Low Return
DuPont ROE decomposition for CAD.V (quarterly period ending 2025-04-30)
ROE: -3.0430664211644425%
Asset turnover: 0
Equity multiplier (leverage): 1.0055229181092449
ROE archetype: Low Return
DuPont ROE decomposition for CAD.V (quarterly period ending 2025-10-31)
ROE: -2.2542447010037576%
Asset turnover: 0
Equity multiplier (leverage): 1.0053390151381105
ROE archetype: Low Return
DuPont ROE decomposition for CAD.V (quarterly period ending 2026-01-31)
ROE: -11.974502784822723%
Asset turnover: 0
Equity multiplier (leverage): 1.005262749888789
ROE archetype: Low Return
DuPont ROE decomposition for CAD.V (quarterly period ending 2026-04-30)
ROE: -1.8656429327444102%
Asset turnover: 0
Equity multiplier (leverage): 1.0038964301975881
ROE archetype: Low Return
DuPont ROE decomposition for CAF.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 9.25293434530439
ROE archetype: Standard Business
DuPont ROE decomposition for CAF.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 8.689789984711236
ROE archetype: Standard Business
DuPont ROE decomposition for CALN.SW (annual period ending 2022-12-31)
ROE: 18.616994541561535%
Net margin: 11.60877427766408%
Asset turnover: 0.9551048143037174
Equity multiplier (leverage): 1.6790830225474722
EBIT margin: 9.09991255809872%
Interest burden factor: 0.9892199070087825
Tax burden factor: 1.2896037880370448
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CALN.SW (annual period ending 2023-12-31)
ROE: -44.97396567709677%
Net margin: -25.88509612951696%
Asset turnover: 0.9537450812881325
Equity multiplier (leverage): 1.8217093642108708
EBIT margin: 0.5395242377176489%
Interest burden factor: -30.5
ROE archetype: Low Return
DuPont ROE decomposition for CALN.SW (annual period ending 2024-12-31)
ROE: 14.320466855250755%
Net margin: 6.460730083707725%
Asset turnover: 1.0855302039009562
Equity multiplier (leverage): 2.0418962294147316
EBIT margin: 1.8308359519048485%
Interest burden factor: 0.8066193853427895
Tax burden factor: 4.374853458382181
ROE archetype: Standard Business
DuPont ROE decomposition for CALN.SW (annual period ending 2025-12-31)
ROE: 12.807487119275066%
Net margin: 5.089534679055461%
Asset turnover: 1.3310288287305807
Equity multiplier (leverage): 1.8905944903146714
EBIT margin: 4.2965529380158785%
Interest burden factor: 1.0485122897800776
Tax burden factor: 1.1297552950853382
ROE archetype: Standard Business
DuPont ROE decomposition for CAPACITE.NS (annual period ending 2023-03-31)
ROE: 8.877601525023799%
Net margin: 5.343220660668527%
Asset turnover: 0.6828051913924159
Equity multiplier (leverage): 2.4333003773526554
EBIT margin: 15.148959752703185%
Interest burden factor: 0.5031900600703967
Tax burden factor: 0.7009519438278116
ROE archetype: Standard Business
DuPont ROE decomposition for CAPACITE.NS (annual period ending 2024-03-31)
ROE: 9.229897514012602%
Net margin: 6.269372000449741%
Asset turnover: 0.6615863141888833
Equity multiplier (leverage): 2.2252885132423783
EBIT margin: 12.426454781550266%
Interest burden factor: 0.7017948500783632
Tax burden factor: 0.7188969138129528
ROE archetype: Standard Business
DuPont ROE decomposition for CAPACITE.NS (annual period ending 2025-03-31)
ROE: 12.439353095730269%
Net margin: 8.736918999079908%
Asset turnover: 0.693054131766033
Equity multiplier (leverage): 2.054340032671938
EBIT margin: 13.16725823009647%
Interest burden factor: 0.8633164601890944
Tax burden factor: 0.7685868242603554
ROE archetype: Standard Business
DuPont ROE decomposition for CAPACITE.NS (annual period ending 2026-03-31)
ROE: 10.13811772818774%
Net margin: 7.420475892225868%
Asset turnover: 0.6686563749141219
Equity multiplier (leverage): 2.04325505560758
EBIT margin: 12.703958395188982%
Interest burden factor: 0.782572250855624
Tax burden factor: 0.7463941922074427
ROE archetype: Standard Business
DuPont ROE decomposition for CAPITALSFB.NS (annual period ending 2023-03-31)
ROE: 15.328293460956367%
Net margin: 25.19763854081443%
Asset turnover: 0.046484641845802505
Equity multiplier (leverage): 13.086529109299905
Tax burden factor: 0.7538669467471254
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CAPITALSFB.NS (annual period ending 2024-03-31)
ROE: 12.271557035359036%
Net margin: 26.996840996840994%
Asset turnover: 0.047451678666309255
Equity multiplier (leverage): 9.579330135820669
Tax burden factor: 0.7524364301718607
ROE archetype: Standard Business
DuPont ROE decomposition for CAPITALSFB.NS (annual period ending 2025-03-31)
ROE: 10.251198709001843%
Net margin: 26.531177769523907%
Asset turnover: 0.05052304820061692
Equity multiplier (leverage): 7.647660099723546
Tax burden factor: 0.7517228895780383
ROE archetype: Standard Business
DuPont ROE decomposition for CAPITALSFB.NS (annual period ending 2026-03-31)
ROE: 9.62066456940053%
Net margin: 25.26345374508216%
Asset turnover: 0.0480535812967555
Equity multiplier (leverage): 7.924768615640407
Tax burden factor: 0.7488673691079095
ROE archetype: Standard Business
DuPont ROE decomposition for CAPLIPOINT.NS (annual period ending 2023-03-31)
ROE: 19.765948187723815%
Net margin: 25.93099558404754%
Asset turnover: 0.6634206443369536
Equity multiplier (leverage): 1.1489720909991767
EBIT margin: 27.400916206958215%
Interest burden factor: 1.1330203835726478
Tax burden factor: 0.8352498061371442
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CAPLIPOINT.NS (annual period ending 2024-03-31)
ROE: 21.541207692530264%
Net margin: 27.472834985561605%
Asset turnover: 0.6821958616976888
Equity multiplier (leverage): 1.1493637345618293
EBIT margin: 29.65079932124676%
Interest burden factor: 1.1333935742971888
Tax burden factor: 0.8174972981592049
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CAPLIPOINT.NS (annual period ending 2025-03-31)
ROE: 20.44268595367881%
Net margin: 27.927658234708154%
Asset turnover: 0.6483481965418564
Equity multiplier (leverage): 1.129003085015557
EBIT margin: 29.98601268664805%
Interest burden factor: 1.164913850973372
Tax burden factor: 0.7995064865983037
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CAPLIPOINT.NS (annual period ending 2026-03-31)
ROE: 19.06819139881376%
Net margin: 29.70615264334603%
Asset turnover: 0.5766914753569752
Equity multiplier (leverage): 1.1130625288354228
EBIT margin: 31.459543981089887%
Interest burden factor: 1.1667102662481106
Tax burden factor: 0.8093399270045716
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CARM.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.9718906262703542
ROE archetype: Standard Business
DuPont ROE decomposition for CARM.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.967228962861746
ROE archetype: Standard Business
DuPont ROE decomposition for CART (annual period ending 2022-12-31)
Net margin: 16.777734221873775%
Asset turnover: 0.6952848187517034
EBIT margin: 2.4304194433555466%
Interest burden factor: 1.1451612903225807
Tax burden factor: 6.028169014084507
ROE archetype: Standard Business
DuPont ROE decomposition for CART (annual period ending 2023-12-31)
ROE: -88.00868149755833%
Net margin: -53.32018408941486%
Asset turnover: 0.7246307765602668
Equity multiplier (leverage): 2.277807921866522
EBIT margin: -70.41420118343196%
ROE archetype: Low Return
DuPont ROE decomposition for CART (annual period ending 2024-12-31)
ROE: 13.35671489112962%
Net margin: 13.528715216104203%
Asset turnover: 0.764080524768152
Equity multiplier (leverage): 1.2921233377173755
EBIT margin: 14.47602131438721%
Interest burden factor: 1.1288343558282208
Tax burden factor: 0.8278985507246377
ROE archetype: Standard Business
DuPont ROE decomposition for CART (annual period ending 2025-12-31)
ROE: 15.932988772054893%
Net margin: 11.945483698556922%
Asset turnover: 0.9592412201999487
Equity multiplier (leverage): 1.3904829798609875
EBIT margin: 13.308391234633884%
Interest burden factor: 1.1164658634538152
Tax burden factor: 0.8039568345323741
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAT.AX (annual period ending 2022-03-31)
ROE: -28.82589129321729%
Net margin: -41.6695882513342%
Asset turnover: 0.40852018650837857
Equity multiplier (leverage): 1.6933627960872026
EBIT margin: -44.94306156103515%
ROE archetype: Low Return
DuPont ROE decomposition for CAT.AX (annual period ending 2023-03-31)
ROE: -31.625655527594613%
Net margin: -37.293741109530586%
Asset turnover: 0.4439056854125454
Equity multiplier (leverage): 1.9103497117133528
EBIT margin: -38.87743006164059%
ROE archetype: Low Return
DuPont ROE decomposition for CAT.AX (annual period ending 2024-03-31)
ROE: -20.808903288861185%
Net margin: -16.67933282668693%
Asset turnover: 0.5817097546052099
Equity multiplier (leverage): 2.1446882400835636
EBIT margin: -15.117395304187834%
ROE archetype: Low Return
DuPont ROE decomposition for CAT.AX (annual period ending 2025-03-31)
ROE: -10.341319553987253%
Net margin: -7.512486483703208%
Asset turnover: 0.6794861548498586
Equity multiplier (leverage): 2.025870323863739
EBIT margin: -6.892882275200385%
ROE archetype: Low Return
DuPont ROE decomposition for CAT.AX (annual period ending 2026-03-31)
ROE: -16.6630654714781%
Net margin: -17.0263567433895%
Asset turnover: 0.5892631957351747
Equity multiplier (leverage): 1.6608249303015643
EBIT margin: -15.476503485570944%
ROE archetype: Low Return
DuPont ROE decomposition for CATO (quarterly period ending 2025-01-31)
ROE: -8.658254054320501%
Net margin: -8.898796142081832%
Asset turnover: 0.34907739615041966
Equity multiplier (leverage): 2.7872590821708485
EBIT margin: -9.677092502643928%
ROE archetype: Low Return
DuPont ROE decomposition for CATO (quarterly period ending 2025-04-30)
ROE: 2.022535779446416%
Net margin: 1.9437036688948675%
Asset turnover: 0.3812097849562288
Equity multiplier (leverage): 2.729619544455752
EBIT margin: 1.7827563116034821%
Interest burden factor: 1.3960461285008237
Tax burden factor: 0.7809771064432381
ROE archetype: Low Return
DuPont ROE decomposition for CATO (quarterly period ending 2025-07-31)
ROE: 4.053420666987048%
Net margin: 3.870624160807664%
Asset turnover: 0.4022117098025275
Equity multiplier (leverage): 2.6036701493334284
EBIT margin: 2.915432074285164%
Interest burden factor: 1.2706956859696852
Tax burden factor: 1.0448080746291482
ROE archetype: Low Return
DuPont ROE decomposition for CATO (quarterly period ending 2025-10-31)
ROE: -3.0539248142426247%
Net margin: -3.339081865098261%
Asset turnover: 0.35035248974769984
Equity multiplier (leverage): 2.6105142352681527
EBIT margin: -5.490920322775769%
ROE archetype: Low Return
DuPont ROE decomposition for CATO (quarterly period ending 2026-01-31)
ROE: -6.530690119953963%
Net margin: -6.996617411429589%
Asset turnover: 0.34798101533756054
Equity multiplier (leverage): 2.6823497190406145
EBIT margin: -9.047270521367015%
ROE archetype: Low Return
DuPont ROE decomposition for CATO (quarterly period ending 2026-04-30)
ROE: 5.745959341890445%
Net margin: 5.440550776136152%
Asset turnover: 0.3976393186606073
Equity multiplier (leverage): 2.6560139991790606
EBIT margin: 5.025014026556947%
Interest burden factor: 1.1434054431263085
Tax burden factor: 0.9469026548672567
ROE archetype: Standard Business
DuPont ROE decomposition for CATR.TO (quarterly period ending 2025-03-31)
ROE: 11.084670724958492%
Net margin: 14.057126815916906%
Asset turnover: 0.16768658648527784
Equity multiplier (leverage): 4.702490315439954
EBIT margin: 18.099515755491613%
Interest burden factor: 0.996510275300504
Tax burden factor: 0.7793774319066148
ROE archetype: Standard Business
DuPont ROE decomposition for CATR.TO (quarterly period ending 2025-06-30)
ROE: 12.114029257839446%
Net margin: 13.151065242319996%
Asset turnover: 0.19296159246105318
Equity multiplier (leverage): 4.773718562654256
EBIT margin: 17.26115034099825%
Interest burden factor: 0.9853146853146854
Tax burden factor: 0.7732434350603266
ROE archetype: Standard Business
DuPont ROE decomposition for CATR.TO (quarterly period ending 2025-09-30)
ROE: 11.61778911740198%
Net margin: 13.040027213969838%
Asset turnover: 0.19030498377068103
Equity multiplier (leverage): 4.681605658832985
EBIT margin: 17.303549155233018%
Interest burden factor: 1.0245740498034077
Tax burden factor: 0.7355292612727854
ROE archetype: Standard Business
DuPont ROE decomposition for CATR.TO (quarterly period ending 2025-12-31)
ROE: 11.525981339383806%
Net margin: 12.554225683374277%
Asset turnover: 0.20038910864989334
Equity multiplier (leverage): 4.581565154652164
EBIT margin: 13.902681231380337%
Interest burden factor: 1.137593984962406
Tax burden factor: 0.7937871777924653
ROE archetype: Standard Business
DuPont ROE decomposition for CATR.TO (quarterly period ending 2026-03-31)
ROE: 12.653511417992028%
Net margin: 14.636807349985645%
Asset turnover: 0.17809097784868178
Equity multiplier (leverage): 4.854257229933498
EBIT margin: 17.714613838644848%
Interest burden factor: 1.0408427876823338
Tax burden factor: 0.7938336966677046
ROE archetype: Standard Business
DuPont ROE decomposition for CATX (quarterly period ending 2025-03-31)
ROE: -6.385849040032321%
Asset turnover: 0
Equity multiplier (leverage): 1.157051766235135
ROE archetype: Low Return
DuPont ROE decomposition for CATX (quarterly period ending 2025-06-30)
ROE: -7.8079431330257645%
Asset turnover: 0
Equity multiplier (leverage): 1.1630582715681483
ROE archetype: Low Return
DuPont ROE decomposition for CATX (quarterly period ending 2025-09-30)
ROE: -10.225867676823363%
Asset turnover: 0
Equity multiplier (leverage): 1.192243477165156
ROE archetype: Low Return
DuPont ROE decomposition for CATX (quarterly period ending 2025-12-31)
ROE: -16.690150407237%
Asset turnover: 0
Equity multiplier (leverage): 1.2505303318664343
ROE archetype: Low Return
DuPont ROE decomposition for CATX (quarterly period ending 2026-03-31)
ROE: -9.446515495005132%
Asset turnover: 0
Equity multiplier (leverage): 1.2223244221047525
ROE archetype: Low Return
DuPont ROE decomposition for CBAV3.SA (annual period ending 2022-12-31)
ROE: 17.98159360883874%
Net margin: 10.84743865094808%
Asset turnover: 0.7189278275934128
Equity multiplier (leverage): 2.3057683915981984
EBIT margin: 12.132422140901818%
Interest burden factor: 1.0557469777451078
Tax burden factor: 0.8468760339937328
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CBAV3.SA (annual period ending 2023-12-31)
ROE: -16.875579588315066%
Net margin: -11.016897369063186%
Asset turnover: 0.5917034448229735
Equity multiplier (leverage): 2.5887809026042867
EBIT margin: -6.679824775685905%
ROE archetype: Low Return
DuPont ROE decomposition for CBAV3.SA (annual period ending 2024-12-31)
ROE: -1.4569479997812695%
Net margin: -0.8917559342222794%
Asset turnover: 0.5254001232335338
Equity multiplier (leverage): 3.1096239547720907
EBIT margin: 1.9357816808624886%
Interest burden factor: -2.2668179290120336
ROE archetype: Low Return
DuPont ROE decomposition for CBAV3.SA (annual period ending 2025-12-31)
ROE: 5.695320737179058%
Net margin: 2.6153067365192304%
Asset turnover: 0.6700772581368044
Equity multiplier (leverage): 3.2499050726231573
EBIT margin: 0.6334541576054151%
Interest burden factor: 6.341152802974512
Tax burden factor: 0.651087298282587
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (quarterly period ending 2025-03-31)
ROE: 5.628804384447789%
Net margin: 20.97071129707113%
Asset turnover: 0.1378745399374661
Equity multiplier (leverage): 1.9467891556793424
EBIT margin: 29.631799163179917%
Interest burden factor: 0.9889861621011014
Tax burden factor: 0.7155910908052542
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (quarterly period ending 2025-06-30)
ROE: 5.157285131399991%
Net margin: 20.034086067319983%
Asset turnover: 0.1324821061663167
Equity multiplier (leverage): 1.943096564734787
EBIT margin: 30.353642948444826%
Interest burden factor: 0.9393599101628298
Tax burden factor: 0.7026300059772863
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (quarterly period ending 2025-09-30)
ROE: 6.299476439790576%
Net margin: 26.34667600945958%
Asset turnover: 0.1260370151626382
Equity multiplier (leverage): 1.8970575916230366
EBIT margin: 32.84575632828239%
Interest burden factor: 1.1469333333333334
Tax burden factor: 0.6993722390141828
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (quarterly period ending 2025-12-31)
ROE: 6.2554872695346795%
Net margin: 26.038205980066447%
Asset turnover: 0.13105546454481629
Equity multiplier (leverage): 1.8331371218772448
EBIT margin: 35.61461794019933%
Interest burden factor: 1.0534048507462686
Tax burden factor: 0.6940447199468673
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (quarterly period ending 2026-03-31)
ROE: 7.33841968073974%
Net margin: 30.303268384663735%
Asset turnover: 0.1249319048483748
Equity multiplier (leverage): 1.938383530889096
EBIT margin: 39.72344437460716%
Interest burden factor: 1.0195806962025316
Tax burden factor: 0.7482056256062075
ROE archetype: Standard Business
DuPont ROE decomposition for CBSM.PA (annual period ending 2022-06-30)
ROE: 14.332752768278265%
Net margin: 180.259020412514%
Asset turnover: 0.038344971910054954
Equity multiplier (leverage): 2.0735961555575333
EBIT margin: 75.25981985823162%
Interest burden factor: 2.3951561504142767
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CBSM.PA (annual period ending 2023-06-30)
ROE: 3.8999497034430606%
Net margin: 46.81574866176397%
Asset turnover: 0.042135967226527064
Equity multiplier (leverage): 1.9770336700415632
EBIT margin: 74.94121766971836%
Interest burden factor: 0.6246995994659545
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CBSM.PA (annual period ending 2024-06-30)
ROE: 0.12864832480172025%
Net margin: 1.5171137835337647%
Asset turnover: 0.04562698515114656
Equity multiplier (leverage): 1.8585070292841845
EBIT margin: 76.79463459759481%
Interest burden factor: 0.019514545564054686
Tax burden factor: 1.0123456790123457
ROE archetype: Low Return
DuPont ROE decomposition for CBSM.PA (annual period ending 2025-06-30)
ROE: 5.201068414878541%
Net margin: 56.995875648587514%
Asset turnover: 0.04873852008960207
Equity multiplier (leverage): 1.8723058672220105
EBIT margin: 81.7331145505344%
Interest burden factor: 0.6973412913727618
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CBV.V (quarterly period ending 2024-11-30)
ROE: -6.725418584495785%
Net margin: -72.48089558023857%
Asset turnover: 0.08821505299929304
Equity multiplier (leverage): 1.0518482031348617
EBIT margin: -8.66662360018088%
ROE archetype: Low Return
DuPont ROE decomposition for CBV.V (quarterly period ending 2025-02-28)
ROE: -0.6902293461155703%
Net margin: -5.725703306306463%
Asset turnover: 0.11484393763119563
Equity multiplier (leverage): 1.049678991702343
EBIT margin: -4.214050500315411%
ROE archetype: Low Return
DuPont ROE decomposition for CBV.V (quarterly period ending 2025-05-31)
ROE: -1.175583927220963%
Net margin: -12.033154740791907%
Asset turnover: 0.09289376847896902
Equity multiplier (leverage): 1.051689545114832
EBIT margin: -18.38631993578136%
ROE archetype: Low Return
DuPont ROE decomposition for CBV.V (quarterly period ending 2025-11-30)
ROE: -1.0559744927303463%
Net margin: -13.929935899636586%
Asset turnover: 0.07168930217382438
Equity multiplier (leverage): 1.0574259325147422
EBIT margin: -19.86866046424946%
ROE archetype: Low Return
DuPont ROE decomposition for CBV.V (quarterly period ending 2026-02-28)
ROE: -10.430317623685422%
Net margin: -128.24257509978463%
Asset turnover: 0.07661787047091907
Equity multiplier (leverage): 1.0615372214554462
EBIT margin: -130.8075627269766%
ROE archetype: Low Return
DuPont ROE decomposition for CBY.AX (annual period ending 2021-06-30)
ROE: -11.243772626441748%
Equity multiplier (leverage): 1.0196933658357903
ROE archetype: Low Return
DuPont ROE decomposition for CBY.AX (annual period ending 2022-06-30)
ROE: -14.937918312958997%
Equity multiplier (leverage): 1.0205986680364656
ROE archetype: Low Return
DuPont ROE decomposition for CBY.AX (annual period ending 2023-06-30)
ROE: -7.080714853311183%
Equity multiplier (leverage): 1.0231009828413806
ROE archetype: Low Return
DuPont ROE decomposition for CBY.AX (annual period ending 2024-06-30)
ROE: -6.272373877466215%
Equity multiplier (leverage): 1.0677699961337874
ROE archetype: Low Return
DuPont ROE decomposition for CCAQ (annual period ending 2025-12-31)
ROE: 4.703057623167515%
Asset turnover: 0
Equity multiplier (leverage): 1.0417173188966486
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CCC (quarterly period ending 2024-12-31)
ROE: 0.30997741027243353%
Net margin: 2.280800830707012%
Asset turnover: 0.08622249560036416
Equity multiplier (leverage): 1.5762390926079797
EBIT margin: 7.6905980726139935%
Interest burden factor: 0.48948266060261514
Tax burden factor: 0.6058846302748742
ROE archetype: Low Return
DuPont ROE decomposition for CCC (quarterly period ending 2025-03-31)
ROE: -0.8301719195932677%
Net margin: -6.925049192057718%
Asset turnover: 0.07404382320607857
Equity multiplier (leverage): 1.6190353879782566
EBIT margin: -4.252976367936716%
ROE archetype: Low Return
DuPont ROE decomposition for CCC (quarterly period ending 2025-06-30)
ROE: 0.6008609558603648%
Net margin: 4.975983966273886%
Asset turnover: 0.07257696416837903
Equity multiplier (leverage): 1.6637812050136653
EBIT margin: 9.395241331382872%
Interest burden factor: 0.23690232938291786
Tax burden factor: 2.2356391236846647
ROE archetype: Low Return
DuPont ROE decomposition for CCC (quarterly period ending 2025-12-31)
ROE: 0.413930916357408%
Net margin: 2.6429710640236954%
Asset turnover: 0.0860726144357023
Equity multiplier (leverage): 1.8195770971820073
EBIT margin: 16.30569931321811%
Interest burden factor: 0.660811242414564
Tax burden factor: 0.24528757854035765
ROE archetype: Low Return
DuPont ROE decomposition for CCC (quarterly period ending 2026-03-31)
ROE: 0.8789222840463377%
Net margin: 5.481112789974225%
Asset turnover: 0.07985979994946212
Equity multiplier (leverage): 2.0079528869834897
EBIT margin: 17.355612834414718%
Interest burden factor: 0.6847000020484667
Tax burden factor: 0.4612415856394914
ROE archetype: Low Return
DuPont ROE decomposition for CCD (annual period ending 2022-10-31)
ROE: -44.203731621680674%
Asset turnover: -0.2718694727204523
Equity multiplier (leverage): 1.6215583301796244
ROE archetype: Low Return
DuPont ROE decomposition for CCD (annual period ending 2023-10-31)
ROE: -3.462878009580476%
Asset turnover: -0.020441784911218945
Equity multiplier (leverage): 1.6405308209640925
ROE archetype: Low Return
DuPont ROE decomposition for CCD (annual period ending 2024-10-31)
ROE: 23.634411181595258%
Net margin: 99.57805913363676%
Asset turnover: 0.1459596746459961
Equity multiplier (leverage): 1.6261037190234842
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CCD (annual period ending 2025-10-31)
ROE: 23.76635646783758%
Net margin: 99.64034547107062%
Asset turnover: 0.1559000828822282
Equity multiplier (leverage): 1.5299633800708246
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CCEP.MC (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.4613244296048973
ROE archetype: Standard Business
DuPont ROE decomposition for CCEP.MC (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.6039349324929364
ROE archetype: Standard Business
DuPont ROE decomposition for CCEP.MC (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.6683722037125186
ROE archetype: Standard Business
DuPont ROE decomposition for CCHH (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7991441683882132
ROE archetype: Standard Business
DuPont ROE decomposition for CCHH (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.8000182799269486
ROE archetype: Standard Business
DuPont ROE decomposition for CCHH (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8193011758005784
ROE archetype: Standard Business
DuPont ROE decomposition for CCM (annual period ending 2022-12-31)
ROE: -24.292873241826367%
Net margin: -103.72305834754334%
Asset turnover: 0.07861618462417738
Equity multiplier (leverage): 2.979144765205589
EBIT margin: -111.21895421375389%
ROE archetype: Low Return
DuPont ROE decomposition for CCM (annual period ending 2023-12-31)
ROE: -15.641164561566006%
Net margin: -55.388331267840464%
Asset turnover: 0.08818330343257497
Equity multiplier (leverage): 3.202317881423571
EBIT margin: -86.15245198194276%
ROE archetype: Low Return
DuPont ROE decomposition for CCM (annual period ending 2024-12-31)
ROE: -18.07123986382683%
Net margin: -80.28081342653846%
Asset turnover: 0.05933437406993944
Equity multiplier (leverage): 3.7937597183720495
EBIT margin: -138.59921449332734%
ROE archetype: Low Return
DuPont ROE decomposition for CCM (annual period ending 2025-12-31)
ROE: -5.457252111911411%
Net margin: -20.153828447839693%
Asset turnover: 0.07086274559806986
Equity multiplier (leverage): 3.8211887014601125
EBIT margin: -51.97073698245218%
ROE archetype: Low Return
DuPont ROE decomposition for CCR.AX (annual period ending 2022-06-30)
ROE: -20.930619580954914%
Net margin: -58.601248718665545%
Asset turnover: 0.27952591820786665
Equity multiplier (leverage): 1.2777713058962539
EBIT margin: -41.1191874009878%
ROE archetype: Low Return
DuPont ROE decomposition for CCR.AX (annual period ending 2023-06-30)
ROE: -17.855291526406326%
Net margin: -31.638579725901977%
Asset turnover: 0.44580327731134944
Equity multiplier (leverage): 1.2659213051363876
EBIT margin: -26.165202712368746%
ROE archetype: Low Return
DuPont ROE decomposition for CCR.AX (annual period ending 2024-06-30)
ROE: -7.485323608156873%
Net margin: -10.706887931239732%
Asset turnover: 0.5439906122253275
Equity multiplier (leverage): 1.2851562086627089
EBIT margin: -11.773529201685673%
ROE archetype: Low Return
DuPont ROE decomposition for CCR.AX (annual period ending 2025-06-30)
ROE: 5.683800479202902%
Net margin: 7.555091428327862%
Asset turnover: 0.5687250435858501
Equity multiplier (leverage): 1.3228078006433839
EBIT margin: -4.605515536422147%
ROE archetype: Standard Business
DuPont ROE decomposition for CCT.L (quarterly period ending 2025-02-28)
Equity multiplier (leverage): 1.355850266273719
ROE archetype: Standard Business
DuPont ROE decomposition for CCT.L (quarterly period ending 2025-08-31)
Equity multiplier (leverage): 1.6493948220253818
ROE archetype: Standard Business
DuPont ROE decomposition for CCT.L (quarterly period ending 2026-02-28)
Equity multiplier (leverage): 1.7709063557728468
ROE archetype: Standard Business
DuPont ROE decomposition for CDA.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.7272973710786195
ROE archetype: Standard Business
DuPont ROE decomposition for CDI.PA (annual period ending 2022-12-31)
ROE: 27.068527451485807%
Net margin: 18.567116679085157%
Asset turnover: 0.6000939742783306
Equity multiplier (leverage): 2.429410465073462
EBIT margin: 26.46906532967935%
Interest burden factor: 0.958824371391765
Tax burden factor: 0.7315883757961783
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDI.PA (annual period ending 2023-12-31)
ROE: 28.35547692160198%
Net margin: 18.47991364200898%
Asset turnover: 0.64483591061776
Equity multiplier (leverage): 2.3795114762478495
EBIT margin: 26.3136512947895%
Interest burden factor: 0.9539920599911778
Tax burden factor: 0.7361631294215564
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDI.PA (annual period ending 2024-12-31)
ROE: 19.682149849451175%
Net margin: 15.24290876455445%
Asset turnover: 0.5710037034348195
Equity multiplier (leverage): 2.2613394474522583
EBIT margin: 22.612833896223517%
Interest burden factor: 0.9451146273956866
Tax burden factor: 0.7132279809923748
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDI.PA (annual period ending 2025-12-31)
ROE: 17.763620329856604%
Net margin: 13.81934733377059%
Asset turnover: 0.6012436080094541
Equity multiplier (leverage): 2.1379299802849583
EBIT margin: 20.967242936874282%
Interest burden factor: 0.9855987723543647
Tax burden factor: 0.668722678004671
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDNA (annual period ending 2022-12-31)
ROE: -17.779309416561656%
Net margin: -23.808162390107928%
Asset turnover: 0.5926304487551359
Equity multiplier (leverage): 1.2601001134805099
EBIT margin: -24.000211315970205%
ROE archetype: Low Return
DuPont ROE decomposition for CDNA (annual period ending 2023-12-31)
ROE: -54.976388212741554%
Net margin: -67.88002454302878%
Asset turnover: 0.5551976249161977
Equity multiplier (leverage): 1.4587692978870015
EBIT margin: -38.19259142991681%
ROE archetype: Low Return
DuPont ROE decomposition for CDNA (annual period ending 2024-12-31)
ROE: 16.427697218179915%
Net margin: 15.743367736716749%
Asset turnover: 0.6969273684694052
Equity multiplier (leverage): 1.4972403757028014
EBIT margin: -16.637955570202376%
Tax burden factor: 0.9941353411907149
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDNA (annual period ending 2025-12-31)
ROE: -6.2664518571340535%
Net margin: -5.622358842037362%
Asset turnover: 0.8400182244840635
Equity multiplier (leverage): 1.3268274216693519
EBIT margin: -6.601018943931755%
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (annual period ending 2022-12-31)
ROE: 3.508348905901501%
Net margin: 1.271194770191138%
Asset turnover: 1.168094562599502
Equity multiplier (leverage): 2.3627222858520707
EBIT margin: 4.602292955789943%
Interest burden factor: 0.44482938636040054
Tax burden factor: 0.6209324655926598
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (annual period ending 2023-12-31)
ROE: 21.286757819816447%
Net margin: 8.007966311042583%
Asset turnover: 1.1724306337630341
Equity multiplier (leverage): 2.2672537267388693
EBIT margin: 12.16727595268293%
Interest burden factor: 0.901432440258214
Tax burden factor: 0.7301224397248886
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDRE (annual period ending 2024-12-31)
ROE: 14.206657662917726%
Net margin: 6.366364144118429%
Asset turnover: 1.0472648566462341
Equity multiplier (leverage): 2.1308059928009326
EBIT margin: 12.821176930761627%
Interest burden factor: 0.745080255057168
Tax burden factor: 0.6664391899369213
ROE archetype: Standard Business
DuPont ROE decomposition for CDRE (annual period ending 2025-12-31)
ROE: 14.027544059531017%
Net margin: 7.232249945928941%
Asset turnover: 0.8579308716114775
Equity multiplier (leverage): 2.260767591634767
EBIT margin: 12.29657812121093%
Interest burden factor: 0.8304928911215638
Tax burden factor: 0.7081956165966049
ROE archetype: Standard Business
DuPont ROE decomposition for CDS.DE (annual period ending 2022-12-31)
ROE: 30.925940025055436%
Net margin: 23.835463672306453%
Asset turnover: 0.6933363389371102
Equity multiplier (leverage): 1.8713513797064092
EBIT margin: 30.14671571415817%
Interest burden factor: 0.9735709076956175
Tax burden factor: 0.8121121562557695
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDS.DE (annual period ending 2023-12-31)
ROE: 33.86173314270177%
Net margin: 25.455930655997356%
Asset turnover: 0.7569449007001486
Equity multiplier (leverage): 1.757340572649228
EBIT margin: 30.861670431145733%
Interest burden factor: 1.0155976923527892
Tax burden factor: 0.8121716854170989
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDS.DE (annual period ending 2024-12-31)
ROE: 26.132798471474274%
Net margin: 22.741304954857124%
Asset turnover: 0.6338804366820397
Equity multiplier (leverage): 1.812855501507889
EBIT margin: 29.79468524091713%
Interest burden factor: 1.009378457533355
Tax burden factor: 0.7561754066967136
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDS.DE (annual period ending 2025-12-31)
ROE: 21.85483514143369%
Net margin: 20.935217177145496%
Asset turnover: 0.5538332767833757
Equity multiplier (leverage): 1.8849117327283786
EBIT margin: 31.1469900744965%
Interest burden factor: 0.9225727535957803
Tax burden factor: 0.7285523470756082
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDXS (quarterly period ending 2025-03-31)
ROE: -41.685304962824155%
Net margin: -274.2675328118786%
Asset turnover: 0.05852413354333641
Equity multiplier (leverage): 2.597009812811058
EBIT margin: -271.5895532281586%
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (quarterly period ending 2025-06-30)
ROE: -25.2175565266958%
Net margin: -86.5866388308977%
Asset turnover: 0.11475931464850841
Equity multiplier (leverage): 2.5378396351890555
EBIT margin: -83.91179540709813%
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (quarterly period ending 2025-09-30)
ROE: -41.65649057605522%
Net margin: -228.0548773398442%
Asset turnover: 0.06560465586349716
Equity multiplier (leverage): 2.7842527209981416
EBIT margin: -220.31159167538655%
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (quarterly period ending 2025-12-31)
ROE: 21.557598823436958%
Net margin: 24.67172041629192%
Asset turnover: 0.2863945127650336
Equity multiplier (leverage): 3.0509582028224043
EBIT margin: 35.888474881151225%
Interest burden factor: 0.6887440927967922
Tax burden factor: 0.9981287036074435
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CDXS (quarterly period ending 2026-03-31)
ROE: -18.56595885370562%
Net margin: -57.08289611752361%
Asset turnover: 0.11002752852973118
Equity multiplier (leverage): 2.956038096050681
EBIT margin: -52.747901364113325%
ROE archetype: Low Return
DuPont ROE decomposition for CENTENKA.NS (annual period ending 2023-03-31)
ROE: 6.8335716609543695%
Net margin: 4.390412257377711%
Asset turnover: 1.2678400848016467
Equity multiplier (leverage): 1.2276596227614227
EBIT margin: 4.957199313633514%
Interest burden factor: 1.1539517552461267
Tax burden factor: 0.7675050985723997
ROE archetype: Standard Business
DuPont ROE decomposition for CENTENKA.NS (annual period ending 2024-03-31)
ROE: 3.158644378238544%
Net margin: 2.4648577589686234%
Asset turnover: 1.040933409735628
Equity multiplier (leverage): 1.231078998971813
EBIT margin: 1.9407511617984523%
Interest burden factor: 1.7091503267973858
Tax burden factor: 0.7430905614462021
ROE archetype: Low Return
DuPont ROE decomposition for CENTENKA.NS (annual period ending 2025-03-31)
ROE: 4.71902544190509%
Net margin: 3.3206940135585428%
Asset turnover: 1.140754513798405
Equity multiplier (leverage): 1.2457510550623383
EBIT margin: 2.9869760052755425%
Interest burden factor: 1.5377153370128784
Tax burden factor: 0.722971503154231
ROE archetype: Low Return
DuPont ROE decomposition for CENTENKA.NS (annual period ending 2026-03-31)
ROE: 6.591790848906815%
Net margin: 5.9129476196339885%
Asset turnover: 0.8936206270151168
Equity multiplier (leverage): 1.2475162245842304
EBIT margin: 5.416292856263303%
Interest burden factor: 1.39298473530367
Tax burden factor: 0.7837102665734048
ROE archetype: Standard Business
DuPont ROE decomposition for CEPU (quarterly period ending 2025-03-31)
ROE: 4.138014128226089%
Net margin: 40.81515803586713%
Asset turnover: 0.07103512987308527
Equity multiplier (leverage): 1.4272409829226596
EBIT margin: 32.675315586593904%
Interest burden factor: 1.649370007771958
Tax burden factor: 0.7573272757239776
ROE archetype: Low Return
DuPont ROE decomposition for CEPU (quarterly period ending 2025-06-30)
ROE: 3.7218030586317328%
Net margin: 39.92318579233407%
Asset turnover: 0.06598546704537185
Equity multiplier (leverage): 1.4127974541094879
EBIT margin: 33.30227275730859%
Interest burden factor: 1.169520150847988
Tax burden factor: 1.0250465947445864
ROE archetype: Low Return
DuPont ROE decomposition for CEPU (quarterly period ending 2025-09-30)
ROE: 5.548169799632831%
Net margin: 43.79084721296174%
Asset turnover: 0.08738991996614127
Equity multiplier (leverage): 1.4497898500135196
EBIT margin: 34.43402502981219%
Interest burden factor: 1.0820131782190185
Tax burden factor: 1.1753386192904094
ROE archetype: Standard Business
DuPont ROE decomposition for CEPU (quarterly period ending 2025-12-31)
ROE: 1.0051404012265146%
Net margin: 8.34636654616346%
Asset turnover: 0.08283264751265443
Equity multiplier (leverage): 1.453877225120347
EBIT margin: -9.346953439072887%
Tax burden factor: 0.22224247746759748
ROE archetype: Low Return
DuPont ROE decomposition for CEPU (quarterly period ending 2026-03-31)
ROE: 7.471772756573442%
Net margin: 57.05292458939899%
Asset turnover: 0.09144587793252285
Equity multiplier (leverage): 1.432127253688312
EBIT margin: 31.886693027727382%
Interest burden factor: 1.4482149615239057
Tax burden factor: 1.2354790940766551
ROE archetype: Standard Business
DuPont ROE decomposition for CEV (annual period ending 2022-11-30)
ROE: -21.54482895688674%
Asset turnover: -0.13614748161117704
Equity multiplier (leverage): 1.5397902631451659
ROE archetype: Low Return
DuPont ROE decomposition for CEV (annual period ending 2023-11-30)
ROE: 3.0572916426611076%
Net margin: 86.02284317200373%
Asset turnover: 0.02416317135087319
Equity multiplier (leverage): 1.4708525676963795
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CEV (annual period ending 2024-11-30)
ROE: 6.658191027856225%
Net margin: 92.5223895601838%
Asset turnover: 0.0528309358369282
Equity multiplier (leverage): 1.3621379936701423
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CEV (annual period ending 2025-11-30)
ROE: 0.006773803392468715%
Net margin: 1.310936181503943%
Asset turnover: 0.003649138913974433
Equity multiplier (leverage): 1.4159914823992557
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CFYN.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.429203834376248
ROE archetype: Standard Business
DuPont ROE decomposition for CFYN.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 3.414422453895951
ROE archetype: Standard Business
DuPont ROE decomposition for CFYN.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 3.299325700957403
ROE archetype: Standard Business
DuPont ROE decomposition for CFYN.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 3.4199189274519592
ROE archetype: Standard Business
DuPont ROE decomposition for CGI.L (annual period ending 2022-12-31)
ROE: -25.279535571472866%
Asset turnover: -0.21768555312480298
Equity multiplier (leverage): 1.1505864980244696
ROE archetype: Low Return
DuPont ROE decomposition for CGI.L (annual period ending 2023-12-31)
ROE: 16.44314917822459%
Net margin: 98.00946587052805%
Asset turnover: 0.145639822330582
Equity multiplier (leverage): 1.151958501029015
Tax burden factor: 0.9978113397809047
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGI.L (annual period ending 2024-12-31)
ROE: 23.391198224950294%
Net margin: 95.24808152359648%
Asset turnover: 0.21431283057207517
Equity multiplier (leverage): 1.1459035372663013
Tax burden factor: 0.9585920742422253
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGI.L (annual period ending 2025-12-31)
ROE: 17.158186707358208%
Net margin: 97.21442720369758%
Asset turnover: 0.15632966620684993
Equity multiplier (leverage): 1.1290138435204489
Tax burden factor: 0.9803051454037142
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGI.TO (annual period ending 2022-12-31)
ROE: -25.27953557147286%
Asset turnover: -0.21768555312480295
Equity multiplier (leverage): 1.1505864980244696
ROE archetype: Low Return
DuPont ROE decomposition for CGI.TO (annual period ending 2023-12-31)
ROE: 16.29773713796884%
Net margin: 98.00946587052806%
Asset turnover: 0.14435340309573186
Equity multiplier (leverage): 1.1519463679665483
Tax burden factor: 0.9978113397809049
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGI.TO (annual period ending 2024-12-31)
ROE: 22.68154227459019%
Net margin: 95.24808152359647%
Asset turnover: 0.20777134458093524
Equity multiplier (leverage): 1.146121592832561
Tax burden factor: 0.9585920742422253
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGI.TO (annual period ending 2025-12-31)
ROE: 16.890969801540994%
Net margin: 97.2144272036976%
Asset turnover: 0.15387157842050692
Equity multiplier (leverage): 1.1291859221309346
Tax burden factor: 0.9803051454037143
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGNT.V (quarterly period ending 2025-03-31)
ROE: -91.44738459986318%
Asset turnover: 0
Equity multiplier (leverage): 1.3392440861469392
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (quarterly period ending 2025-06-30)
ROE: -228.84933873260985%
Asset turnover: 0
Equity multiplier (leverage): 1.8790499450237748
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (quarterly period ending 2025-09-30)
ROE: -211.26189967564747%
Asset turnover: 0
Equity multiplier (leverage): 1.587341728096306
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (quarterly period ending 2025-12-31)
ROE: -62.26707274044476%
Asset turnover: 0
Equity multiplier (leverage): 1.417572721198272
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (quarterly period ending 2026-03-31)
ROE: -74.59592528860493%
Asset turnover: 0
Equity multiplier (leverage): 1.187297229962648
ROE archetype: Low Return
DuPont ROE decomposition for CGNX (annual period ending 2022-12-31)
ROE: 14.983724904302994%
Net margin: 21.422039777753483%
Asset turnover: 0.5137988090739171
Equity multiplier (leverage): 1.3613377141450813
EBIT margin: 26.703873410927454%
Interest burden factor: 0.933113728993356
Tax burden factor: 0.8597100061828118
ROE archetype: Standard Business
DuPont ROE decomposition for CGNX (annual period ending 2023-12-31)
ROE: 7.694759281394807%
Net margin: 13.519718893387475%
Asset turnover: 0.42130639404097436
Equity multiplier (leverage): 1.3509190505669784
EBIT margin: 14.650162916230371%
Interest burden factor: 1.1030627047643886
Tax burden factor: 0.8366137659958034
ROE archetype: Standard Business
DuPont ROE decomposition for CGNX (annual period ending 2024-12-31)
ROE: 7.025941208838295%
Net margin: 11.609541669628163%
Asset turnover: 0.45604192026154283
Equity multiplier (leverage): 1.327042008671003
EBIT margin: 12.582079025494389%
Interest burden factor: 1.1427367140311997
Tax burden factor: 0.8074515738959153
ROE archetype: Standard Business
DuPont ROE decomposition for CGNX (annual period ending 2025-12-31)
ROE: 7.605620511157351%
Net margin: 11.509122962632208%
Asset turnover: 0.4960132488486446
Equity multiplier (leverage): 1.3322911564607767
EBIT margin: 16.34882371457391%
Interest burden factor: 1.124478673277315
Tax burden factor: 0.6260434787365565
ROE archetype: Standard Business
DuPont ROE decomposition for CGTL (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.212458329049103
ROE archetype: Standard Business
DuPont ROE decomposition for CGTL (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.098837778364742
ROE archetype: Standard Business
DuPont ROE decomposition for CGX.DE (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.9582664904640774
ROE archetype: Standard Business
DuPont ROE decomposition for CHC.AX (annual period ending 2022-06-30)
ROE: 28.178861294342944%
Net margin: 90.37730330505994%
Asset turnover: 0.24464532748175358
Equity multiplier (leverage): 1.2744627169650729
EBIT margin: 48.63995320269085%
Interest burden factor: 2.2176788935658447
Tax burden factor: 0.8378524945770064
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHC.AX (annual period ending 2023-06-30)
ROE: 5.870356264736149%
Net margin: 24.968169085816147%
Asset turnover: 0.1861427043396848
Equity multiplier (leverage): 1.2630825723946777
EBIT margin: 45.28902470078941%
Interest burden factor: 0.9046949676693843
Tax burden factor: 0.6093847110006215
ROE archetype: Standard Business
DuPont ROE decomposition for CHC.AX (annual period ending 2024-06-30)
ROE: -7.3370039026872504%
Net margin: -44.66117031972652%
Asset turnover: 0.12934808512045634
Equity multiplier (leverage): 1.270072892895639
EBIT margin: 44.54051880152825%
Interest burden factor: -0.5760722347629798
ROE archetype: Low Return
DuPont ROE decomposition for CHC.AX (annual period ending 2025-06-30)
ROE: 11.729518799802134%
Net margin: 74.10673903211217%
Asset turnover: 0.12180519597497458
Equity multiplier (leverage): 1.299441335583072
EBIT margin: 47.73857982813206%
Interest burden factor: 1.9891046897205116
Tax burden factor: 0.7804239104548703
ROE archetype: Standard Business
DuPont ROE decomposition for CHCO (annual period ending 2022-12-31)
ROE: 17.663865488048845%
Net margin: 41.479124505238175%
Asset turnover: 0.04186348459861051
Equity multiplier (leverage): 10.172338245779196
Tax burden factor: 0.8016005151805488
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHCO (annual period ending 2023-12-31)
ROE: 18.226688915132303%
Net margin: 40.49422320420079%
Asset turnover: 0.04689013708769219
Equity multiplier (leverage): 9.599159466993063
Tax burden factor: 0.7991628583008399
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHCO (annual period ending 2024-12-31)
ROE: 16.636855078743793%
Net margin: 41.07913366215069%
Asset turnover: 0.045149356828911094
Equity multiplier (leverage): 8.970122821847939
Tax burden factor: 0.8102978216944836
ROE archetype: Leverage-Driven Returns